All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F16%3A43874484" target="_blank" >RIV/62157124:16370/16:43874484 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.jdiacomp.2016.01.010" target="_blank" >http://dx.doi.org/10.1016/j.jdiacomp.2016.01.010</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.jdiacomp.2016.01.010" target="_blank" >10.1016/j.jdiacomp.2016.01.010</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy

  • Original language description

    Aim: To study the correlation between serum antimyeloperoxidase (MPO) antibody levels with severity of diabetic retinopathy (DR). Methods: Study subjects included 60 consecutive cases of type 2 diabetes mellitus (DM): no diabetic retinopathy (NODR, n = 20); nonproliferative DR (NPDR, n = 20); proliferative DR (PDR, n = 20) and 20 healthy controls. Best corrected visual acuity (BCVA) was measured on logMAR scale. Serum anti-MPO antibody levels were evaluated using ELISA IgG kit. Serum urea and creatinine was measured using standard protocol. Data were analysed statistically. Results: Mean serum anti-MPO antibody (RU/ml) was 16.94 +/- 4.85 in controls, 17.66 +/- 4.78 in NODR, 21.51 +/- 5.27 in NPDR and 37.27 +/- 11.92 in PDR groups. On ANOVA, significant difference in visual acuity was found among the study groups (F = 73.46, p < 0.001). Serum anti-MPO antibody was correlated significantly with decrease in visual acuity (F = 48.40, p < 0.001), increase in serum urea (F = 128.13, p < 0.001) and creatinine (F = 77.10, p < 0.001). Conclusion: Increase in serum anti-MPO antibody levels correlate with increased severity of DR. Serum anti-MPO antibody may be a noteworthy biochemical marker for progression of retinopathy from nonproliferative to proliferative stage.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    CE - Biochemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of diabetes and its complications

  • ISSN

    1056-8727

  • e-ISSN

  • Volume of the periodical

    30

  • Issue of the periodical within the volume

    4

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    5

  • Pages from-to

    700-704

  • UT code for WoS article

    000374916200022

  • EID of the result in the Scopus database